Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Comment by CleverInvestor2on Nov 18, 2020 7:46pm
208 Views
Post# 31927763

RE:best performer

RE:best performer
100% agree, been in and still holding as low as 60Cents... increased my position a few more times and averaged around $4.50 and looks to add more shares in the near future. A pullback is likely to happen by next week unless if news comes out. Regardless, great investment and have made a killing off Tril and I hold long as I watch my holdings increase with time.
<< Previous
Bullboard Posts
Next >>